Maple Securities USA’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
O
O
BIT
BFA
Maple Securities USA's BLUE Position: Q3 2015 in Review
Maple Securities USA sold out of bluebird bio (BLUE) in Q3 2015, closing a stake of 212 shares — an estimated $463K sold.
Maple Securities USA first reported a position in BLUE in Q2 2015 and held it in 1 quarter. The position peaked at $463K in Q2 2015. 192 funds tracked by Wall St. Rank hold BLUE as of Q3 2015.
- Maple Securities USA reported no remaining bluebird bio position as of Q3 2015 after selling out during the quarter.
- Maple Securities USA sold 212 bluebird bio shares in Q3 2015, an estimated $463K.
- Maple Securities USA first reported a position in bluebird bio in Q2 2015 and held it in 1 quarter.
- Maple Securities USA's bluebird bio position peaked at $463K in Q2 2015.
- 192 funds tracked by Wall St. Rank held bluebird bio as of Q3 2015.
Based on Maple Securities USA's 13F filing for Q3 2015, filed 3 Nov 2015.